Treatment OutcomeOutcome Assessment (Health Care)Retrospective StudiesFollow-Up StudiesPrognosisPregnancy OutcomeProspective StudiesTime FactorsKaplan-Meier EstimateSurvival AnalysisRisk FactorsSurvival RatePredictive Value of TestsOutcome and Process Assessment (Health Care)Cohort StudiesSeverity of Illness IndexRecurrencePostoperative ComplicationsMultivariate AnalysisRisk AssessmentProportional Hazards ModelsRandomized Controlled Trials as TopicPregnancyMyocardial InfarctionAngioplasty, Balloon, CoronaryStentsDisease ProgressionInfant, NewbornLength of StayRecovery of FunctionStrokeLogistic ModelsAcute DiseaseChi-Square DistributionQuality of LifeUnited StatesTumor Markers, BiologicalAge FactorsGlasgow Outcome ScaleDrug-Eluting StentsNeoplasm StagingRegistriesHospital MortalityDisease-Free SurvivalCombined Modality TherapyIncidenceCoronary AngiographyBiological MarkersReoperationPatient SatisfactionDouble-Blind MethodHospitalizationProsthesis DesignTreatment FailureTomography, X-Ray ComputedBreast NeoplasmsReproducibility of ResultsCost-Benefit AnalysisPatient Outcome AssessmentFibrinolytic AgentsResearch DesignLongitudinal StudiesPatient SelectionThrombolytic TherapyChronic DiseaseImmunohistochemistryRegression AnalysisNeoplasm Recurrence, LocalPilot ProjectsMagnetic Resonance ImagingCoronary Artery DiseasePain MeasurementDrug Therapy, CombinationSpinal FusionPlatelet Aggregation InhibitorsDisability EvaluationOdds RatioStatistics, NonparametricSirolimusClinical Trials as TopicAntineoplastic Combined Chemotherapy ProtocolsSingle-Blind MethodRange of Motion, ArticularGenotypeBrain IschemiaEvidence-Based MedicineSensitivity and SpecificityCoronary Artery BypassAnalysis of VarianceCase-Control StudiesHeart FailureCardiovascular AgentsAnti-Bacterial AgentsNeurosurgical ProceduresClinical ProtocolsMyocardial RevascularizationFeasibility StudiesAntineoplastic AgentsKidney Failure, ChronicDecompression, Surgical